Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults

References

• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
   Google Scholar
• Genovese G, Kahler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477–2487.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488–2498.
   PubMed Web of Science ®Google Scholar
• Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20:1472–1478.
   PubMed Web of Science ®Google Scholar
• Age limits of pediatrics. Pediatrics. 1972;49:463.
   PubMed Web of Science ®Google Scholar
• Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet. 2011;204:227–244.
   PubMed Web of Science ®Google Scholar
• Godley LA. Inherited predisposition to acute myeloid leukemia. Sem Hematol. 2014;51:306–321.
   PubMed Web of Science ®Google Scholar
• Nickels EM, Soodalter J, Churpek JE, Godley LA. Recognizing familial myeloid leukemia in adults. Ther Adv Hematol. 2013;4:254–269.
   PubMedGoogle Scholar
• Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia – a review. Br J Haematol. 2008;140:123–132.
   PubMed Web of Science ®Google Scholar
• Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica. 2011;96: 1536–1542.
   PubMed Web of Science ®Google Scholar
• Churpek JE, Lorenz R, Nedumgottil S, et al. Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes. Leuk Lymphoma. 2013;54:28–35.
   PubMed Web of Science ®Google Scholar
• Sekeres MA. The epidemiology of myelodysplastic syndromes. Hematol Oncol Clin North Am. 2010;24:287–294.
   PubMed Web of Science ®Google Scholar
• Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109:1536–1542.
   PubMed Web of Science ®Google Scholar
• SEER. July 8. <http://seer.cancer.gov/archive/csr/1975_ 2011/results_merged/sect_30_mds.pdf>. Accessed 2015 July 8.
   Google Scholar
• Roddam PL, Rollinson S, Kane E, et al. Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. Pharmacogenetics. 2000;10:605–615.
   PubMedGoogle Scholar
• Rollinson S, Roddam P, Kane E, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis. 2000;21:43–47.
   PubMed Web of Science ®Google Scholar
• Das P, Shaik AP, Bammidi VK. Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia. Leuk Lymphoma. 2009;50:1345–1351.
   PubMed Web of Science ®Google Scholar
• Kuendgen A, Strupp C, Aivado M, et al. Myelodysplastic syndromes in patients younger than age 50. J Clin Oncol. 2006;24:5358–5365.
   PubMed Web of Science ®Google Scholar
• Glaubach T, Robinson LJ, Corey SJ. Pediatric myelodysplastic syndromes: they do exist! J Pediatr Hematol Oncol. 2014;36:1–7.
   PubMed Web of Science ®Google Scholar
• Goldin LR, Kristinsson SY, Liang XS, et al. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2012;30:179–183.
   PubMed Web of Science ®Google Scholar
• Rochowski A, Olson SB, Alonzo TA, et al. Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer. 2012;59:922–924.
   PubMed Web of Science ®Google Scholar
• Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009;113:6549–6557.
   PubMed Web of Science ®Google Scholar
• Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood. 2000;96:429–436.
   PubMed Web of Science ®Google Scholar
• Myers KC, Davies SM, Shimamura A. Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update. Hematol Oncol Clin North Am. 2013;27:117–128, ix.
   PubMed Web of Science ®Google Scholar
• Maciejewski JP, Selleri C. Evolution of clonal cytogenetic abnormalities in aplastic anemia. Leuk Lymphoma. 2004;45:433–440.
   PubMed Web of Science ®Google Scholar
• Xiao H, Shi J, Luo Y, et al. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2011;117:5257–5260.
   PubMed Web of Science ®Google Scholar
• Fogarty PF, Yamaguchi H, Wiestner A, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003;362:1628–1630.
   PubMed Web of Science ®Google Scholar
• Orfali RF, Wynn RF, Stevens RF, et al. Failure of red cell production following allogenic BMT for Diamond Blackfan anaemia (DBA) illustrates functional significance of high erythrocyte adenosine deaminase (eADA) activity in the donor [abstract]. Blood. 1999;94:414.
   Web of Science ®Google Scholar
• Owen CJ, Toze CL, Koochin A, et al. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 2008;112:4639–4645.
   PubMed Web of Science ®Google Scholar
• Gyger M, Perreault C, Belanger R, et al. Unsuspected Fanconi's anemia and bone marrow transplantation in cases of acute myelomonocytic leukemia. N Engl J Med. 1989;321:120–121.
   PubMed Web of Science ®Google Scholar
• Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822–826.
   PubMed Web of Science ®Google Scholar
• Alter BP, Giri N, Savage SA, et al. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol. 2010;150:179–188.
   PubMed Web of Science ®Google Scholar
• Ghemlas I, Li H, Zlateska B, et al. Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes. J Med Genet. 2015;52:575–584.
   PubMed Web of Science ®Google Scholar
• Zhang MY, Keel SB, Walsh T, et al. Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity. Haematologica. 2015;100:42–48.
   PubMed Web of Science ®Google Scholar
• Laboratories TUoCGS. 2015 July 10. Next Generation Sequencing Panel for Inherited Bone Marrow Failure Syndromes. <http://dnatesting.uchicago.edu/sites/default/files/01%20NGS%20Leukemia_10.pdf>. Accessed 2015 July 10.
   Google Scholar
• Laboratories TUoCGS. 2015 July 10. Next Generation Sequencing Panel for Familial Myelodysplastic Syndrome/Acute Leukemia (MDS/AL). <http://dnatesting.uchicago.edu/sites/default/files/01%20NGS%20Bone%20Marrow%20Failure_6.pdf>. Accessed 2015 July 10.
   Google Scholar
• Laboratories CCsCaMG. 2013 July 10. Bone Marrow Failure Syndromes Panel by NGS. <http://www.cincinnatichildrens.org/WorkArea/linkit.aspx?LinkIdentifier=id&ItemID=105263&libID=104957>. Accessed 2015 July 10.
   Google Scholar
• Fargo JH, Rochowski A, Giri N, et al. Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes. Cytogenet Genome Res. 2014;144:15–27.
   PubMed Web of Science ®Google Scholar
• Du HY, Pumbo E, Ivanovich J, et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood. 2009;113:309–316.
   PubMed Web of Science ®Google Scholar
• Soulier J, Leblanc T, Larghero J, et al. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood. 2005;105:1329–1336.
   PubMed Web of Science ®Google Scholar
• Casanova JL, Conley ME, Seligman SJ, et al. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med. 2014;211:2137–2149.
   PubMed Web of Science ®Google Scholar
• Tiu RV, Gondek LP, O'Keefe CL, et al. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Blood. 2011;117:4552–4560.
   PubMed Web of Science ®Google Scholar
• Ganapathi KA, Townsley DM, Hsu AP, et al. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015;125:56–70.
   PubMed Web of Science ®Google Scholar
• DeZern AE, Symons HJ, Resar LS, et al. Detection of paroxysmal nocturnal hemoglobinuria clones to exclude inherited bone marrow failure syndromes. Eur J Haematol. 2014;92:467–470.
   PubMed Web of Science ®Google Scholar
• Holme H, Hossain U, Kirwan M, et al. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia. Br J Haematol. 2012;158:242–248.
   PubMed Web of Science ®Google Scholar
• Cada M, Segbefia CI, Klaassen R, et al. The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes. Haematologica. 2015;100:633–642.
   PubMed Web of Science ®Google Scholar
• Bessler M, Mason PJ, Link DC, Wilson DB. Inherited bone marrrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, Fisher DE, Lux S, editors. Nathans and Oski's hematology of infancy and childhood. 7 ed: Saunders; 2008. p. 307–396.
   Google Scholar
• Alter BP. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program. Education Program. 2007:29–39.
   Google Scholar
• Khincha PP, Savage SA. Genomic characterization of the inherited bone marrow failure syndromes. Sem Hematol. 2013;50:333–347.
   PubMed Web of Science ®Google Scholar
• Dokal I, Vulliamy T. Inherited aplastic anaemias/bone marrow failure syndromes. Blood Rev. 2008;22:141–153.
   PubMed Web of Science ®Google Scholar
• D'Orazio JA. Inherited cancer syndromes in children and young adults. J Pediatr Hematol Oncol. 2010;32: 195–228.
   PubMed Web of Science ®Google Scholar
• Pippucci T, Savoia A, Perrotta S, et al. Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet. 2011;88:115–120.
   PubMed Web of Science ®Google Scholar
• Al Daama SA, Housawi YH, Dridi W, et al. A missense mutation in ANKRD26 segregates with thrombocytopenia. Blood. 2013;122:461–462.
   PubMed Web of Science ®Google Scholar
• Necchi V, Balduini A, Noris P, et al. Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. Thromb Haemost. 2013;109:263–271.
   PubMed Web of Science ®Google Scholar
• Bluteau D, Balduini A, Balayn N, et al. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest. 2014;124:580–591.
   PubMed Web of Science ®Google Scholar
• Noris P, Perrotta S, Seri M, et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood. 2011;117:6673–6680.
   PubMed Web of Science ®Google Scholar
• Boutroux H, Petit A, Auvrignon A, et al. Childhood diagnosis of genetic thrombocytopenia with mutation in the ankyrine repeat domain 26 gene. Eur J Pediatr. 2015;174:1399–1403.
   PubMed Web of Science ®Google Scholar
• Noris P, Favier R, Alessi MC, et al. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013;122:1987–1989.
   PubMed Web of Science ®Google Scholar
• Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med. 2004;351: 2403–2407.
   PubMed Web of Science ®Google Scholar
• Pabst T, Eyholzer M, Haefliger S, et al. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. J Clin Oncol. 2008;26:5088–5093.
   PubMed Web of Science ®Google Scholar
• Taskesen E, Bullinger L, Corbacioglu A, et al. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. Blood. 2011;117:2469–2475.
   PubMed Web of Science ®Google Scholar
• Roe JS, Vakoc CR. C/EBPalpha: critical at the origin of leukemic transformation. J Exp Med. 2014;211:1–4.
   PubMed Web of Science ®Google Scholar
• Renneville A, Mialou V, Philippe N, et al. Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation. Leukemia. 2009;23:804–806.
   PubMed Web of Science ®Google Scholar
• Tawana K, Wang J, Renneville A, et al. Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood. 2015;126:1214–1223.
   PubMed Web of Science ®Google Scholar
• Debeljak M, Kitanovski L, Pajic T, Jazbec J. Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein alpha with 13 years difference at onset. Haematologica. 2013;98:e73–e74.
   PubMed Web of Science ®Google Scholar
• Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809–821.
   PubMed Web of Science ®Google Scholar
• Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43:929–931.
   PubMed Web of Science ®Google Scholar
• Calvo KR, Vinh DC, Maric I, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica. 2011;96:1221–1225.
   PubMed Web of Science ®Google Scholar
• Vinh DC, Patel SY, Uzel G, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115:1519–1529.
   PubMed Web of Science ®Google Scholar
• Mansour S, Connell F, Steward C, et al. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am J Med Genet A. 2010;152A:2287–2296.
   PubMed Web of Science ®Google Scholar
• Collin M, Dickinson R, Bigley V. Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol. 2015;169:173–187.
   PubMed Web of Science ®Google Scholar
• Rodrigues NP, Janzen V, Forkert R, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood. 2005;106:477–484.
   PubMed Web of Science ®Google Scholar
• Lim KC, Hosoya T, Brandt W, et al. Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest. 2012;122: 3705–3717.
   PubMed Web of Science ®Google Scholar
• Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119:1283–1291.
   PubMed Web of Science ®Google Scholar
• Pasquet M, Bellanne-Chantelot C, Tavitian S, et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 2013;121:822–829.
   PubMed Web of Science ®Google Scholar
• Dickinson RE, Milne P, Jardine L, et al. The evolution of cellular deficiency in GATA2 mutation. Blood. 2014;123:863–874.
   PubMed Web of Science ®Google Scholar
• West RR, Hsu AP, Holland SM, et al. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica. 2014;99: 276–281.
   PubMed Web of Science ®Google Scholar
• Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23:166–175.
   PubMed Web of Science ®Google Scholar
• Beri-Dexheimer M, Latger-Cannard V, Philippe C, et al. Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur J Hum Genet. 2008;16:1014–1018.
   PubMed Web of Science ®Google Scholar
• Michaud J, Wu F, Osato M, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood. 2002;99:1364–1372.
   PubMed Web of Science ®Google Scholar
• Sakurai M, Kunimoto H, Watanabe N, et al. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients. Leukemia. 2014;28:2344–2354.
   PubMed Web of Science ®Google Scholar
• Jongmans MC, Kuiper RP, Carmichael CL, et al. Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome. Leukemia. 2010;24:242–246.
   PubMed Web of Science ®Google Scholar
• Preudhomme C, Renneville A, Bourdon V, et al. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. Blood. 2009;113:5583–5587.
   PubMed Web of Science ®Google Scholar
• Ganly P, Walker LC, Morris CM. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leuk Lymphoma. 2004;45:1–10.
   PubMed Web of Science ®Google Scholar
• Yoshimi A, Toya T, Kawazu M, et al. Recurrent CDC25C mutations drive malignant transformation in FPD/AML. Nat commun. 2014;5:4770.
   PubMed Web of Science ®Google Scholar
• Kirwan M, Walne AJ, Plagnol V, et al. Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia. Am J Hum Genet. 2012;90:888–892.
   PubMed Web of Science ®Google Scholar
• Polprasert C, Schulze I, Sekeres MA, et al. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Cancer Cell. 2015;27:658–670.
   PubMed Web of Science ®Google Scholar
• Zhang MY, Churpek JE, Keel SB, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015;47:180–185.
   PubMed Web of Science ®Google Scholar
• Noetzli L, Lo RW, Lee-Sherick AB, et al. Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet. 2015;47:535–538.
   PubMed Web of Science ®Google Scholar
• Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 1997;336:1365–1372.
   PubMed Web of Science ®Google Scholar
• Champlin R, Ho W, Gale RP. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med. 1983;308:113–118.
   PubMed Web of Science ®Google Scholar
• Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152–1157.
   PubMed Web of Science ®Google Scholar
• Heuser M, Schlarmann C, Dobbernack V, et al. Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica. 2014;99:e165–e167.
   PubMed Web of Science ®Google Scholar
• Kulasekararaj AG, Jiang J, Smith AE, et al. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood. 2014;124:2698–2704.
   PubMed Web of Science ®Google Scholar
• Lane AA, Odejide O, Kopp N, et al. Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia. 2013;27:968–971.
   PubMed Web of Science ®Google Scholar
• Dumitriu B, Feng X, Townsley DM, et al. Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia. Blood. 2015;125:706–709.
   PubMed Web of Science ®Google Scholar
• Huang J, Ge M, Lu S, et al. Mutations of ASXL1 and TET2 in aplastic anemia. Haematologica. 2015;100:e172–e175.
   PubMed Web of Science ®Google Scholar
• Yoshizato T, Dumitriu B, Hosokawa K, et al. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med. 2015;373:35–47.
   PubMed Web of Science ®Google Scholar
• Babushok DV, Olson TS, Bessler M. Clonal Hematopoiesis in Acquired Aplastic Anemia. N Engl J Med. 2015;373:1673.
   PubMed Web of Science ®Google Scholar
• Babushok DV, Perdigones N, Perin JC, et al. Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. Cancer Genet. 2015;208:115–128.
   PubMed Web of Science ®Google Scholar
• Katagiri T, Sato-Otsubo A, Kashiwase K, et al. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood. 2011;118:6601–6609.
   PubMed Web of Science ®Google Scholar
• Babushok DV, Xie HM, Roth JJ, et al. Single nucleotide polymorphism array analysis of bone marrow failure patients reveals characteristic patterns of genetic changes. Br J Haematol. 2014;164:73–82.
   PubMed Web of Science ®Google Scholar
• Network NCC. August 26, 2015. Myelodysplastic Syndrome. 1.2016. <http://www.nccn.org/professionals/physician_gls/pdf/mds.pdf>. August 26, 2015.
   Google Scholar
• Rosenberg PS, Zeidler C, Bolyard AA, et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010;150:196–199.
   PubMed Web of Science ®Google Scholar
• Ebihara Y, Ishikawa K, Mochizuki S, et al. Allogeneic stem cell transplantation for patients with acute myeloid leukaemia developing from severe congenital neutropenia. Br J Haematol. 2014;164:459–461.
   PubMed Web of Science ®Google Scholar
• Carlsson G, Winiarski J, Ljungman P, et al. Hematopoietic stem cell transplantation in severe congenital neutropenia. Pediatr Blood Cancer. 2011;56:444–451.
   PubMed Web of Science ®Google Scholar
• Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Current opinion in hematology. 2012;19:44–51.
   PubMed Web of Science ®Google Scholar
• Choi SW, Boxer LA, Pulsipher MA, et al. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation. Bone Marrow Transplant. 2005;35:473–477.
   PubMed Web of Science ®Google Scholar
• MacMillan ML, DeFor TE, Young JA, et al. Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood. 2015;125:3798–3804.
   PubMed Web of Science ®Google Scholar
• Mitchell R, Wagner JE, Hirsch B, et al. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. Br J Haematol. 2014;164:384–395.
   PubMed Web of Science ®Google Scholar
• Ayas M, Saber W, Davies SM, et al. Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. J Clin Oncol. 2013;31:1669–1676.
   PubMed Web of Science ®Google Scholar
• Khan NE, Rosenberg PS, Lehmann HP, Alter BP. Preemptive Bone Marrow Transplantation for FANCD1/BRCA2. Biol Blood Marrow Transplant. 2015;21:1796–1780.
   PubMed Web of Science ®Google Scholar
• Gregory JJ Jr, Wagner JE, Verlander PC, et al. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci USA. 2001;98:2532–2537.
   PubMed Web of Science ®Google Scholar
• Parikh S, Perdigones N, Paessler M, et al. Acquired copy number neutral loss of heterozygosity of chromosome 7 associated with clonal haematopoiesis in a patient with Shwachman-Diamond syndrome. Br J Haematol. 2012;159:480–482.
   PubMed Web of Science ®Google Scholar
• Minelli A, Maserati E, Nicolis E, et al. The isochromosome i(7)(q10) carrying c.258 + 2t > c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome. Leukemia. 2009;23:708–711.
   PubMed Web of Science ®Google Scholar
• Pressato B, Valli R, Marletta C, et al. Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis. Br J Haematol. 2012;157:503–505.
   PubMed Web of Science ®Google Scholar
• Hosokawa K, Katagiri T, Sugimori N, et al. Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation. Haematologica. 2012;97:1845–1849.
   PubMed Web of Science ®Google Scholar
• Elias HK, Schinke C, Bhattacharyya S, et al. Stem cell origin of myelodysplastic syndromes. Oncogene. 2014;33:5139–5150.
   PubMed Web of Science ®Google Scholar
• Hasle H, Niemeyer CM. Advances in the prognostication and management of advanced MDS in children. Br J Haematol. 2011;154:185–195.
   PubMed Web of Science ®Google Scholar
• Talbot A, Peffault de Latour R, Raffoux E, et al. Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia. Haematologica. 2014;99:e199–e200.
   PubMed Web of Science ®Google Scholar
• Sekeres MA, Cutler C. How we treat higher-risk myelodysplastic syndromes. Blood. 2014;123:829–836.
   PubMed Web of Science ®Google Scholar
• Nishihori T, Perkins J, Mishra A, et al. Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome. Biol Blood Marrow Transplant. 2014;20:776–780.
   PubMed Web of Science ®Google Scholar
• Cruijsen M, Lubbert M, Wijermans P, Huls G. Clinical Results of Hypomethylating Agents in AML Treatment. J Clin Med. 2014;4:1–17.
   PubMed Web of Science ®Google Scholar
• Cseh A, Niemeyer CM, Yoshimi A, et al. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood. 2015;125:2311–2313.
   PubMed Web of Science ®Google Scholar
• Phillips CL, Davies SM, McMasters R, et al. Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults. Br J Haematol. 2013;161:406–410.
   PubMed Web of Science ®Google Scholar
• Wilson DB, Link DC, Mason PJ, Bessler M. Inherited bone marrow failure syndromes in adolescents and young adults. Ann Med. 2014;46:353–363.
   PubMed Web of Science ®Google Scholar
• Dietz AC, Orchard PJ, Baker KS, et al. Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. Bone Marrow Transplant. 2011;46:98–104.
   PubMed Web of Science ®Google Scholar
• Bhatla D, Davies SM, Shenoy S, et al. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplant. 2008;42:159–165.
   PubMed Web of Science ®Google Scholar
• Yoshimi A, Strahm B, Baumann I, et al. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. Biol Bone Marrow Transplant. 2014;20:425–429.
   PubMed Web of Science ®Google Scholar
• Inagaki J, Fukano R, Kurauchi K, et al. Hematopoietic stem cell transplantation in children with refractory cytopenia of childhood: single-center experience using high-dose cytarabine containing myeloablative and aplastic anemia oriented reduced-intensity conditioning regimens. Biol Bone Marrow Transplant. 2015;21:565–569.
   PubMedGoogle Scholar
• Steele M, Hitzler J, Doyle JJ, et al. Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7. Pediatr Blood Cancer. 2005;45:212–216.
   PubMed Web of Science ®Google Scholar